← Back to headlines
Lilly Pursues $4B M&A Spree After Positive Cholesterol Shot Trials
Following upbeat trial results for its cholesterol shot, pharmaceutical giant Lilly is embarking on a $4 billion merger and acquisition spree.
27 May, 04:01 — 27 May, 04:01
Sources
Showing 1 of 1 sources
